A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Advertisement
The Scientist
Most Recent
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
Early exposure to microbes shapes the mammalian immune system by subduing inflammatory T cells.
The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.
Replacing immune cells in a mouse model of Rett syndrome, a developmental brain disorder, improved symptoms, suggesting a new target for treatment.
A new method for transplanting immunologically mismatched organs may remove the need for life-long immunosuppressive drugs to prevent rejection.
A lot changes in a child’s body over the course of development, and not all changes occur linearly: gene expression can fluctuate, and organs can perform different functions on the way to their final purpose in the body. Here are some of the key deve
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
